SMS Pharmaceuticals informs about disclosure
SMS Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India).
The above information is a part of company’s filings submitted to BSE.
